Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Brazil asks women to delay pregnancy over new coronavirus variant fears

Published 04/16/2021, 03:44 PM
Updated 04/16/2021, 04:11 PM
© Reuters. Outbreak of the coronavirus disease (COVID-19) in Sao Carlos

By Eduardo Simões

SAO PAULO (Reuters) - Brazil asked women on Friday to delay getting pregnant until the worst of the pandemic passes, saying the virus variant that is devastating the South American country appears to affect expectant mothers more than earlier versions of the coronavirus.

The recommendation comes as Brazil continues to be one of the global epicenters of the pandemic, with more Brazilians dying of the virus each day than anywhere else in the world.

Hospitals are buckling under the strain and stocks of drugs needed for intubating severely ill patients are running perilously low, with Brazil turning to international partners for help with emergency supplies.

"If it’s possible, delay pregnancy a little until a better moment," Health Ministry official Raphael Parente said during a news conference on Friday.

He said the recommendation was partly due to the stress on the health system but also due to the more easily transmissible Brazilian variant known as P.1.

"The clinical experience of specialists shows that this new variant acts more aggressively in pregnant women," Parente said.

Previously, COVID-19 cases during pregnancy were focused on the final trimester and birth, whereas lately there have been more serious cases in the second and occasionally first trimester, he said.

Parente did not give any more details.

The P.1 variant, first discovered in the Amazon (NASDAQ:AMZN) city of Manaus, has quickly become dominant in Brazil. It is thought to be a major factor behind a massive second wave of infections that has brought the country's death toll to over 350,000 - the second highest in the world behind the United States.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Brazil's outbreak is increasingly affecting younger people, with hospital data showing that in March more than half of all patients in intensive care were aged 40 or younger.

President Jair Bolsonaro has opposed lockdowns and held large events in which he often does not wear a mask. He has only recently embraced vaccines as a possible solution, but the inoculation rollout has been plagued by delays and missed targets for getting people inoculated.

This week, vaccinations were stopped in several cities due to a shortage of vaccine supply, according to local media.

The surge in COID-19 cases has also left hospitals short of sedatives needed for patients who require mechanical ventilation.

An emergency shipment of the drugs arrived in Brazil late on Thursday from China, while donations from Spain are expected to arrive next week.

Rio de Janeiro and Sao Paulo have both sounded the alarm over shortages, with Sao Paulo's health secretary saying this week that the city's ability to care for seriously ill COVID-19 patients is on the verge of collapse.

Despite the shortage of drugs and 85% of intensive care beds occupied, Sao Paulo announced on Friday it would begin reopening stores and restaurants, saying the number of new hospitalizations had fallen sufficiently to do so safely.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.